Health Condition 1: H518- Other specified disorders of binocular movement
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients meeting following inclusion criteria will be eligible for participation in the study: Ability to give informed consent. Subjects both male and female with age 18 years and above. Patients with any type of non-strabismic, iso ametropic, anisometropic or meridonial amblyopia. Without any systemic or ophthalmic comorbidities Amblyopic patients with acuities between 20/40 (0.30 log MAR) to 20/200 (1.00 Log MAR) Patients with and computer knowledge and ability to play games using computer
Exclusion criteria
Exclusion criteria: Patients meeting any of the following exclusion criteria will not be eligible for participation in the study â?? Patients with Sensory deprivation or Strabismic amblyopia, or has eccentric fixation â?? Patients who have taken treatment for non-strabismic amblyopia within 6 weeks of study recruitment â?? Refractive error greater than 6.00D â?? Patients undergone previous intraocular or refractive surgery â?? Patients with any corneal irregularity â?? Patients with opacification of ocular media including cataracts and active ocular disease â?? Patients suffering from Glaucoma, nystagmus, uncontrolled diabetes, and uncontrolled high blood pressure in the opinion of a PI. â?? Other ocular or systemic diseases that will affect visual acuity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in best-corrected distance visual acuity in the amblyopic eye by 0.2 log MAR improvement compared to baseline after initiating game play.Timepoint: 6 weeks and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| â?? Change from baseline in stereopsis measured using by Titmus test. â??Change from baseline in interocular suppression by performing Worth 4 Dot Test. â?? Change from Baseline in contrast sensitivity at 12 weeks with using Pelli Robson chart â?? Change from baseline in degree of binocular vision at 12 weeks by performing Worth 4 Dot Test. Timepoint: â?¢ 12 weeks â?¢ 12 weeks â?¢ 12 weeks â?¢ 12 weeks | — |
Countries
India
Contacts
Kanohi Eye Private Limited